112 related articles for article (PubMed ID: 23250641)
1. [Cognitive impairment due to intensive use and overdoses of gammahydroxybutyric acid (GHB)].
van Amsterdam JG; Brunt TM; McMaster MT; Niesink R; van Noorden MS; van den Brink W
Tijdschr Psychiatr; 2012; 54(12):1001-10. PubMed ID: 23250641
[TBL] [Abstract][Full Text] [Related]
2. Possible long-term effects of γ-hydroxybutyric acid (GHB) due to neurotoxicity and overdose.
van Amsterdam JG; Brunt TM; McMaster MT; Niesink RJ
Neurosci Biobehav Rev; 2012 Apr; 36(4):1217-27. PubMed ID: 22342779
[TBL] [Abstract][Full Text] [Related]
3. Cognitive Impairment Following Clinical or Recreational Use of Gammahydroxybutyric Acid (GHB): A Systematic Review.
Amsterdam JV; Brunt TM; Pereira FR; Crunelle CL; Brink WVD
Curr Neuropharmacol; 2022; 20(4):809-819. PubMed ID: 34151766
[TBL] [Abstract][Full Text] [Related]
4. Risk assessment of GBL as a substitute for the illicit drug GHB in the Netherlands. A comparison of the risks of GBL versus GHB.
van Amsterdam J; Brunt T; Pennings E; van den Brink W
Regul Toxicol Pharmacol; 2014 Nov; 70(2):507-13. PubMed ID: 25204614
[TBL] [Abstract][Full Text] [Related]
5. Adverse effects of GHB-induced coma on long-term memory and related brain function.
Raposo Pereira F; McMaster MTB; Polderman N; de Vries YDAT; van den Brink W; van Wingen GA
Drug Alcohol Depend; 2018 Sep; 190():29-36. PubMed ID: 29966850
[TBL] [Abstract][Full Text] [Related]
6. The epidemiology of GHB and ketamine use in an Australian household survey.
Degenhardt L; Dunn M
Int J Drug Policy; 2008 Aug; 19(4):311-6. PubMed ID: 17920826
[TBL] [Abstract][Full Text] [Related]
7. Recent trends in the use of "club drugs": an Australian review.
Degenhardt L; Copeland J; Dillon P
Subst Use Misuse; 2005; 40(9-10):1241-56. PubMed ID: 16048815
[TBL] [Abstract][Full Text] [Related]
8. [Gamma-hydroxy butyric acid: neurotransmitter, sedative and party drug].
Meyer S; Kleinschmidt S; Gottschling S; Gortner L; Strittmatter M
Wien Med Wochenschr; 2005 Jul; 155(13-14):315-22. PubMed ID: 16092038
[TBL] [Abstract][Full Text] [Related]
9. Effect of GHB-use and GHB-induced comas on dorsolateral prefrontal cortex functioning in humans.
Raposo Pereira F; McMaster MTB; Polderman N; de Vries YDAT; van den Brink W; van Wingen GA
Neuroimage Clin; 2018; 20():923-930. PubMed ID: 30308378
[TBL] [Abstract][Full Text] [Related]
10. [Gamma-hydroxybutyric acid (GHB): more than a date rape drug, a potentially addictive drug].
Karila L; Novarin J; Megarbane B; Cottencin O; Dally S; Lowenstein W; Reynaud M
Presse Med; 2009 Oct; 38(10):1526-38. PubMed ID: 19762202
[TBL] [Abstract][Full Text] [Related]
11. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
[TBL] [Abstract][Full Text] [Related]
12. Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats.
Pedraza C; García FB; Navarro JF
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1165-77. PubMed ID: 19288974
[TBL] [Abstract][Full Text] [Related]
13. Risk assessment of gamma-hydroxybutyric acid (GHB) in the Netherlands.
van Amsterdam JG; van Laar M; Brunt TM; van den Brink W
Regul Toxicol Pharmacol; 2012 Jun; 63(1):55-63. PubMed ID: 22440552
[TBL] [Abstract][Full Text] [Related]
14. Influence of Gamma-Hydroxybutyric Acid-Use and Gamma-Hydroxybutyric Acid-Induced Coma on Affect and the Affective Network.
Raposo Pereira F; McMaster MTB; de Vries YDAT; Polderman N; van den Brink W; van Wingen GA
Eur Addict Res; 2019; 25(4):173-181. PubMed ID: 30999293
[TBL] [Abstract][Full Text] [Related]
15. Going knock-Recurrent comatose GHB intoxication in the Netherlands & Flanders (Belgium).
Grund JP; de Bruin D; van Gaalen S
Int J Drug Policy; 2018 Aug; 58():137-148. PubMed ID: 29957565
[TBL] [Abstract][Full Text] [Related]
16. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review.
Zvosec DL; Smith SW; Litonjua R; Westfal RE
Clin Toxicol (Phila); 2007; 45(3):261-5. PubMed ID: 17453877
[TBL] [Abstract][Full Text] [Related]
17. A review of tolerability and abuse liability of gamma-hydroxybutyric acid for insomnia in patients with schizophrenia.
Kantrowitz JT; Citrome L; Javitt DC
Clin Ther; 2009 Jun; 31 Pt 1():1360-73. PubMed ID: 19698899
[TBL] [Abstract][Full Text] [Related]
18. Demographic and Clinical Characteristics of Regular GHB-Users with and without GHB-Induced Comas.
Raposo Pereira F; McMaster MTB; de Vries YAT; van den Brink W; van Wingen GA
Subst Use Misuse; 2020; 55(13):2148-2155. PubMed ID: 32772606
[TBL] [Abstract][Full Text] [Related]
19. Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series.
Van Sassenbroeck DK; De Neve N; De Paepe P; Belpaire FM; Verstraete AG; Calle PA; Buylaert WA
Clin Toxicol (Phila); 2007; 45(5):533-8. PubMed ID: 17503262
[TBL] [Abstract][Full Text] [Related]
20. Cognitive Impairments in Patients with GHB Use Disorder Predict Relapse in GHB Use.
Beurmanjer H; Bruijnen CJWH; Greeven PGJ; De Jong CAJ; Schellekens AFA; Dijkstra BAG
Eur Addict Res; 2022; 28(5):350-357. PubMed ID: 35853435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
